SWOG clinical trial number
S1918

A Phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed diffuse large B cell lymphoma, Grade IIIb Follicular Lymphoma, transformed lymphoma, and high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements

Open
Phase
II-III
Accrual
0%
Abbreviated Title
Ph II/III study of R-miniCHOP +/- oral aza in elderly with newly diganosed DLBCL
Status Notes
Activation - Effective 3/19/21, 12:00 pm Pacific Time

Training for Conduct of FIL Tool, accessible from: https://www.swog.org/required-s1918-training.

Online FIL Tool, accessible from: https://redcap.filinf.it/surveys/?s=RF4FPKH799.

Note: Responses must also be submitted in iMedidata RAVE, as indicated in protocol Section 14.5a, along with the score generated by the online FIL Tool.
Activated
03/19/2021
Participants
ALL NATIONAL CLINICAL TRIALS NETWORK MEMBERS LISTED ON TITLE PAGE

Research committees

Lymphoma

Treatment

Cyclophosphamide Prednisone Vincristine Doxorubicin Filgrastim Rituximab Pegfilgrastim CC-486 CHOP

Other Study Materials

Eligibility Criteria Expand/Collapse

* See S1918 protocol Section 5.0; accessible from the CTSU protocol abstract page at www.ctsu.org.